Skip to main content

Table 3 Baseline characteristics of the included children

From: Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment

Gender

  
 

Total

(n = 251)

Percentage

Male

149

59.4%

Female

102

40.6%

Age

  

Mean (SD) in years: 11.8 (3.0)

  

6–11 years

122

48.6%

12–17 years

129

51.4%

Physical characteristics

  

Weight in kg: mean (SD)

47.5 (15.3)

 

Height in cm: mean (SD)

154.6 (17.1)

 

Season with most complaints of allergy

  

Spring

35

13.9%

Autumn

14

5.6%

Spring and autumn/entire year

201

80.1%

Nasal symptoms (scale 0–12)

  

Telephone screening: mean (SD)

6.8 (2.1)

 

Screening visit in last 3 months: mean (SD)

5.8 (2.3)

 

Screening visit in last week: mean (SD)

4.5 (2.6)

 

Asthma

  

Asthma present

92

36.7%

Asthma medication

99

39.4%

Wheeze/breathless – ever

154

62.3%

Wheeze/breathless – last year

131

53.9%

Dry cough at night – last year

130

52.6%

Sensitization

  

One allergen (monosensitized for HDM)

58

23.1%

Two allergens

67

26.7%

Three allergens

72

28.7%

Four allergens

54

21.5%

Sensitization to both HDM and

  

Grass pollen

179

71.3%

Tree pollen

108

43.0%

Cat dander

85

33.9%